Viewing Study NCT06090669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-06-15 @ 4:24 PM
Study NCT ID: NCT06090669
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2023-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Inherited Bone Marrow Failure Syndrome View
None Familial Platelet Disorder With Predisposition to Myeloid Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None predisposition to hematologic malignancies View
None germline mutations View
None IBMFS View